A potential fate decision landscape of the TWEAK/Fn14 axis on stem and progenitor cells: a systematic review.
Fate decision
Stem and progenitor cells
TWEAK/Fn14
Journal
Stem cell research & therapy
ISSN: 1757-6512
Titre abrégé: Stem Cell Res Ther
Pays: England
ID NLM: 101527581
Informations de publication
Date de publication:
21 06 2022
21 06 2022
Historique:
received:
17
03
2022
accepted:
19
05
2022
entrez:
21
6
2022
pubmed:
22
6
2022
medline:
24
6
2022
Statut:
epublish
Résumé
Stem and progenitor cells (SPCs) possess self-remodeling ability and differentiation potential and are responsible for the regeneration and development of organs and tissue systems. However, the precise mechanisms underlying the regulation of SPC biology remain unclear. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) acts on miscellaneous cells via binding to fibroblast growth factor-inducible 14 (Fn14) and exerts pleiotropic functions in the regulation of divergent stem cell fates. TWEAK/Fn14 signaling can regulate the proliferation, differentiation, and migration of multiple SPCs as well as tumorigenesis in certain contexts. Although TWEAK's roles in modulating multiple SPCs are sparsely reported, the systemic effector functions of this multifaceted protein have not been fully elucidated. In this review, we summarized the fate decisions of TWEAK/Fn14 signaling on multiple stem cells and characterized its potential in stem cell therapy.
Identifiants
pubmed: 35729659
doi: 10.1186/s13287-022-02930-z
pii: 10.1186/s13287-022-02930-z
pmc: PMC9210594
doi:
Substances chimiques
Receptors, Tumor Necrosis Factor
0
TWEAK Receptor
0
Tumor Necrosis Factor-alpha
0
Types de publication
Journal Article
Review
Systematic Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
270Informations de copyright
© 2022. The Author(s).
Références
Blood. 2011 Sep 1;118(9):2578-88
pubmed: 21725055
Nat Commun. 2022 May 26;13(1):2940
pubmed: 35618700
J Bone Miner Res. 2009 Aug;24(8):1434-49
pubmed: 19292615
Gynecol Oncol. 2011 Oct;123(1):123-8
pubmed: 21788066
J Immunol. 2007 Jun 15;178(12):8183-94
pubmed: 17548657
Am J Physiol Endocrinol Metab. 2014 Apr 15;306(8):E929-36
pubmed: 24569592
J Cell Mol Med. 2014 Apr;18(4):721-34
pubmed: 24479820
Stem Cell Reports. 2018 May 8;10(5):1464-1480
pubmed: 29628394
Cytotherapy. 2019 Nov;21(11):1137-1150
pubmed: 31668487
Cells. 2020 Sep 01;9(9):
pubmed: 32882817
Mol Cell Biol. 2012 Jun;32(12):2300-11
pubmed: 22493066
Front Immunol. 2013 Dec 19;4:472
pubmed: 24391645
J Cell Physiol. 2014 May;229(5):580-7
pubmed: 24122208
Cell. 2018 Nov 1;175(4):908-920
pubmed: 30388451
J Clin Invest. 2005 Sep;115(9):2330-40
pubmed: 16110324
Cell. 2005 Dec 2;123(5):931-44
pubmed: 16325585
J Cell Physiol. 2021 May;236(5):3304-3316
pubmed: 33000480
Pediatr Diabetes. 2004;5 Suppl 2:16-22
pubmed: 15601370
Mol Immunol. 2010 Apr;47(7-8):1650-60
pubmed: 20299103
Stem Cells. 2015 Mar;33(3):925-38
pubmed: 25385494
Hepatology. 2014 Mar;59(3):1198-201
pubmed: 24038142
JAMA. 2017 Jan 17;317(3):330
pubmed: 28114555
J Hepatol. 2021 Apr;74(4):860-872
pubmed: 33221352
Neuroscience. 2016 May 13;322:377-97
pubmed: 26917272
J Biol Chem. 2006 Apr 14;281(15):10327-36
pubmed: 16461349
PLoS One. 2011 Jan 28;6(1):e16615
pubmed: 21305053
Stem Cells Transl Med. 2016 Apr;5(4):530-8
pubmed: 26956207
Exp Ther Med. 2018 Nov;16(5):4019-4029
pubmed: 30344680
J Exp Orthop. 2016 Dec;3(1):15
pubmed: 27447481
J Clin Endocrinol Metab. 2013 Aug;98(8):3482-90
pubmed: 23760626
Int J Mol Sci. 2020 Jan 21;21(3):
pubmed: 31973111
J Invest Dermatol. 2019 Jan;139(1):224-234
pubmed: 30081003
Cancer Res. 2016 Nov 15;76(22):6533-6542
pubmed: 27634763
Endocrinology. 2009 Dec;150(12):5373-83
pubmed: 19887572
Crit Rev Oncol Hematol. 2018 Mar;123:95-113
pubmed: 29482784
Cell Med. 2013 Apr 29;5(1):1-16
pubmed: 26858860
BMC Cancer. 2015 Oct 24;15:785
pubmed: 26499463
PLoS One. 2013 Aug 26;8(8):e72132
pubmed: 23991053
Inflamm Res. 2016 Jun;65(6):479-88
pubmed: 26921306
PLoS One. 2010 Jan 19;5(1):e8760
pubmed: 20098732
Cell Stem Cell. 2020 Oct 1;27(4):523-531
pubmed: 33007237
Int J Oncol. 2013 Apr;42(4):1239-48
pubmed: 23443741
PLoS One. 2014 Jan 09;9(1):e83987
pubmed: 24416188
J Orthop Translat. 2015 Sep 12;4:1-13
pubmed: 30035061
Trends Genet. 2008 Apr;24(4):159-66
pubmed: 18325627
BMC Dev Biol. 2007 Jun 07;7:63
pubmed: 17555568
Immunity. 2001 Nov;15(5):837-46
pubmed: 11728344
Methods Mol Biol. 2014;1155:31-45
pubmed: 24788171
Atherosclerosis. 2010 Jul;211(1):322-6
pubmed: 20303491
Development. 2012 Aug;139(16):2845-56
pubmed: 22833472
Arthritis Res Ther. 2006;8(5):R146
pubmed: 16945157
J Biol Chem. 2013 Dec 6;288(49):35159-69
pubmed: 24151074
Stem Cells Int. 2016;2016:7849890
pubmed: 26880988
J Biol Chem. 2007 May 18;282(20):15000-10
pubmed: 17383968
EMBO J. 2006 Dec 13;25(24):5826-39
pubmed: 17124496
Nat Commun. 2015 Aug 05;6:7792
pubmed: 26242746
Rev Endocr Metab Disord. 2019 Jun;20(2):187-195
pubmed: 31025266
Hepatology. 2010 Jul;52(1):291-302
pubmed: 20578156
J Cell Sci. 2010 Aug 15;123(Pt 16):2792-802
pubmed: 20663919
Nat Genet. 2006 Feb;38(2):228-33
pubmed: 16380711
Science. 2002 Oct 18;298(5593):597-600
pubmed: 12228720
Cell Rep. 2022 Jun 7;39(10):110927
pubmed: 35675771
Biochem Biophys Res Commun. 2000 Dec 9;279(1):162-5
pubmed: 11112433
Mol Cell Neurosci. 2011 Jan;46(1):325-32
pubmed: 21040786
Sci Signal. 2012 Oct 16;5(246):ra75
pubmed: 23074266
J Immunol. 2005 Aug 1;175(3):1464-72
pubmed: 16034083
J Neurosci Res. 2007 Dec;85(16):3535-44
pubmed: 17803219
Cell Physiol Biochem. 2017;43(2):579-588
pubmed: 28934756
Immunol Rev. 2011 Nov;244(1):99-114
pubmed: 22017434
Mol Biol Rep. 2011 Jan;38(1):587-92
pubmed: 20358293
Am J Pathol. 2010 Oct;177(4):1732-42
pubmed: 20724600
Front Immunol. 2014 Feb 05;5:34
pubmed: 24550918
Cell Stem Cell. 2021 Aug 5;28(8):1343-1361
pubmed: 34129814
Cell. 2017 Jun 1;169(6):985-999
pubmed: 28575679